Market Overview:
The global hemodialysis and peritoneal dialysis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of renal failure, rising geriatric population, and technological advancements in dialysis equipment. Hemodialysis is a process that uses a machine to clean your blood outside your body. During hemodialysis, blood flows from your body through tubes into the machine, where it is cleaned and then returned to you through other tubes. Peritoneal dialysis uses your own body tissues and fluids inside the abdomen (peritoneum) as a filter for removing wastes and extra fluid from the blood.
Product Definition:
Hemodialysis is a medical procedure used to cleanse the blood of toxins. A machine called a dialyzer is connected to the patient's veins, and blood is drawn from the body. The dialyzer separates waste products from the blood and then sends them back into the bloodstream.
Peritoneal dialysis uses a solution called dialysate which is introduced into the peritoneal cavity (the space inside your abdomen). The solution surrounds your abdominal organs and helps remove wastes and excess fluid from your body.
CAPD:
Central Acutely Severe Pain Drug (CAPD) is a drug that provides analgesic and anesthetic properties to patients undergoing dialysis or hemodialysis. It also helps in reducing the severe Central Nervous System (CNS) pain associated with end-stage renal disease. CAPD has been found to be more effective than traditional opiate painkillers in improving chronic kidney disease patient’s quality of life.
APD:
The Advanced Pressure Dialysis (APD) system is a new technology that helps to improve the blood pressure monitoring and treatment in patients suffering from kidney failure. The device works by reducing the pressure inside the patient’s body, thereby making it easier for doctors to access blood vessels and kidneys.
According to statistics provided by WHO, around 661 million people are living with diabetes globally as of 2014.
Application Insights:
The hospital application segment held the largest share of over 70.0% in 2017. The growth is attributed to an increase in the number of patients suffering from chronic kidney diseases (CKD) and growing awareness about hemodialysis and peritoneal dialysis as a treatment option for them. According to U.S Department of Health & Human Services, around 15 million people across the globe are living with CKD, which includes kidney failure and Dialysis-dependent ESRD population (2017).
Household application is expected to be fastest-growing segment owing to increasing adoption rate among working individuals globally who have jobs that require them travel frequently or live away from home for long durations.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large patient pool and favorable reimbursement policies. The U.S., which is at the forefront, accounted for more than 80% of North America’s dialysis procedures in 2017 owing to its high prevalence of kidney failure coupled with a strong healthcare system that caters to people with special needs such as hemodialysis and peritoneal dialysis.
The Asia Pacific region is expected to grow at an exponential rate over the forecast period due to increasing awareness about these therapies among patients, rising healthcare expenditure levels by governments, and growing demand for cost-effective treatment options from patients & their families across various countries including Japan, China India Pakistan Bangladesh etc. In addition, improving economic conditions are also anticipated favorably impact regional growth over next seven years.
Growth Factors:
- Increasing incidence of renal failure: The increasing incidence of renal failure is one of the key growth drivers for the hemodialysis and peritoneal dialysis market. This is because as the number of people suffering from renal failure increases, there will be a corresponding increase in demand for hemodialysis and peritoneal dialysis services.
- Growing awareness about kidney diseases: There is growing awareness about kidney diseases among people across the world, which is driving them to opt for hemodialysis and peritoneal dialysis services. This is because early diagnosis and treatment can help improve patient outcomes significantly.
- Technological advancements in hemodialysis and peritoneal dialysis equipment: The technological advancements in hemodialysis and peritoneal dialysis equipment are helping to improve patient outcomes significantly. This is driving more patients to opt for these treatments over traditional treatments such as conservative management or transplantation surgery .
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemodialysis and Peritoneal Dialysis Market Research Report
By Type
CAPD, APD
By Application
Hospital, Household
By Companies
FRESENIUS MEDICAL CARE, DAVITA HEALTHCARE PARTNERS, BAXTER INTERNATIONAL, B. BRAUN MELSUNGEN, DIAVERUM DEUTSCHLAND, Nipro, NXSTAGE MEDICAL, MAR COR PURIFICATION
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Hemodialysis and Peritoneal Dialysis Market Report Segments:
The global Hemodialysis and Peritoneal Dialysis market is segmented on the basis of:
Types
CAPD, APD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- FRESENIUS MEDICAL CARE
- DAVITA HEALTHCARE PARTNERS
- BAXTER INTERNATIONAL
- B. BRAUN MELSUNGEN
- DIAVERUM DEUTSCHLAND
- Nipro
- NXSTAGE MEDICAL
- MAR COR PURIFICATION
Highlights of The Hemodialysis and Peritoneal Dialysis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CAPD
- APD
- By Application:
- Hospital
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemodialysis and Peritoneal Dialysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemodialysis is a type of dialysis that uses an artificial kidney to clean and remove toxins from the blood. Peritoneal dialysis is a type of dialysis that uses peritoneal fluid (a kind of liquid) to clean and remove toxins from the blood.
Some of the major players in the hemodialysis and peritoneal dialysis market are FRESENIUS MEDICAL CARE, DAVITA HEALTHCARE PARTNERS, BAXTER INTERNATIONAL, B. BRAUN MELSUNGEN, DIAVERUM DEUTSCHLAND, Nipro, NXSTAGE MEDICAL, MAR COR PURIFICATION.
The hemodialysis and peritoneal dialysis market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemodialysis and Peritoneal Dialysis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemodialysis and Peritoneal Dialysis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemodialysis and Peritoneal Dialysis Market - Supply Chain
4.5. Global Hemodialysis and Peritoneal Dialysis Market Forecast
4.5.1. Hemodialysis and Peritoneal Dialysis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemodialysis and Peritoneal Dialysis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemodialysis and Peritoneal Dialysis Market Absolute $ Opportunity
5. Global Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Type
5.3.1. CAPD
5.3.2. APD
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Household
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemodialysis and Peritoneal Dialysis Demand Share Forecast, 2019-2026
9. North America Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Household
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Type
9.7.1. CAPD
9.7.2. APD
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemodialysis and Peritoneal Dialysis Demand Share Forecast, 2019-2026
10. Latin America Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Household
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Type
10.7.1. CAPD
10.7.2. APD
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemodialysis and Peritoneal Dialysis Demand Share Forecast, 2019-2026
11. Europe Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Household
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Type
11.7.1. CAPD
11.7.2. APD
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemodialysis and Peritoneal Dialysis Demand Share, 2019-2026
12. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Household
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Type
12.7.1. CAPD
12.7.2. APD
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemodialysis and Peritoneal Dialysis Demand Share, 2019-2026
13. Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Household
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Size and Volume Forecast by Type
13.7.1. CAPD
13.7.2. APD
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemodialysis and Peritoneal Dialysis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemodialysis and Peritoneal Dialysis Market: Market Share Analysis
14.2. Hemodialysis and Peritoneal Dialysis Distributors and Customers
14.3. Hemodialysis and Peritoneal Dialysis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. FRESENIUS MEDICAL CARE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DAVITA HEALTHCARE PARTNERS
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BAXTER INTERNATIONAL
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. B. BRAUN MELSUNGEN
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DIAVERUM DEUTSCHLAND
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nipro
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NXSTAGE MEDICAL
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. MAR COR PURIFICATION
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
